Feedback / Questions
AG017 - Genten Therapeutics, Intrexon
https://www.prnewswire.com/news-releases/actobio-therapeutics-receives-ind-green-light-for-new-antigen-specific-immunotherapy-study-aimed-at-improving-celiac-patients-tolerance-of-gluten-300903361.html
Aug 19, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next